Detailed Information

Cited 4 time in webofscience Cited 3 time in scopus
Metadata Downloads

Efficacy of Low-Intensity Extracorporeal Shock Wave Therapy for the Treatment of Chronic Pelvic Pain Syndrome IIIb: A Prospective-Randomized, Double-Blind, Placebo-Controlled Study

Authors
Kim, Kang SupChoi, Yong SunBae, Woong JinCho, Hyuk JinHa, U-SynHong, Sung-HooLee, Ji YoulAhn, Sun TaeMoon, Du GeonKim, Sae Woong
Issue Date
Jul-2022
Publisher
대한남성과학회
Keywords
Chronic pelvic pain syndrome; Human; Low-intensity extracorporeal shock wave therapy
Citation
The World Journal of Men's Health, v.40, no.3, pp.473 - 480
Indexed
SCIE
SCOPUS
KCI
Journal Title
The World Journal of Men's Health
Volume
40
Number
3
Start Page
473
End Page
480
URI
https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/54528
DOI
10.5534/wjmh.210010
ISSN
2287-4208
Abstract
Purpose: There is no definite treatment method for chronic pelvic pain syndrome (CPPS). The purpose of this study was to compare and assess the effectiveness and safety of low-intensity extracorporeal shockwave therapy (Li-ESWT) versus placebo treatment in CPPS IIIb patients. Materials and Methods: Thirty participants with CPPS IIIb were included and randomized in this prospective, double-blind, placebo-controlled study. Li-ESWT was performed at the perineum without anesthesia once per week for 8 weeks. CPPS-related symptoms were evaluated using the National Institutes of Health-chronic prostatitis symptom index (NIH-CPSI). Pain and erectile function were appraised using the Visual Analogue Scale (VAS) and International Index of Erectile Function-Erectile Function (IIEF-EF), respectively. The Global Efficacy Assessment Question (GEAQ) was also assessed. The parameters were evaluated immediately after the last Li-ESWT treatment and 4 weeks after Li-EWST treatment. Results: Fifteen subjects each in the Li-ESWT and placebo groups completed this study. Amelioration of NIH-CPSI total, pain, and quality of life score in the Li-ESWT group was found compared to the placebo group (p=0.002, 0.02, 0.001, respec-tively). Improvement of the VAS score was observed in the Li-ESWT group (p=0.002). The differences in the GEAQ "Yes" re-sponses were also significant in the Li-ESWT group. No patients experienced side effects related to ESWT during therapeutic period or follow-up duration. Conclusions: Results indicated that Li-ESWT improved the NIH-CPSI score, pain, and the quality of life in CPPS IIIb patients. Li-ESWT could be an effective alternative treatment modality for CPPS IIIb.
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Urology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Ahn, Sun Tae photo

Ahn, Sun Tae
Guro Hospital (Department of Urology, Guro Hospital)
Read more

Altmetrics

Total Views & Downloads

BROWSE